For: | Celikbilek M, Dogan S, Gursoy S, Zararsız G, Yurci A, Ozbakır O, Guven K, Yucesoy M. Noninvasive assessment of liver damage in chronic hepatitis B. World J Hepatol 2013; 5(8): 439-444 [PMID: 24023983 DOI: 10.4254/wjh.v5.i8.439] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v5/i8/439.htm |
Number | Citing Articles |
1 |
Semih KALYON, Yasemin GÖKDEN. Kronik Hepatit-B hastalarında hematolojik parametrelerin karaciğer inflamasyonu ve fibrozu ile ilişkisi. Mustafa Kemal Üniversitesi Tıp Dergisi 2022; 13(47): 248 doi: 10.17944/mkutfd.972572
|
2 |
Erkin Oztas, Ufuk Baris Kuzu, Neslihan Inci Zengin, Ismail Hakki Kalkan, Fatih Saygili, Hakan Yildiz, Huseyin Tugrul Celik, Meral Akdogan, Mesut Yalin Kilic, Aydin Seref Koksal, Bulent Odemis, Nuretdin Suna, Ertugrul Kayacetin. Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?. Medicine 2015; 94(47): e1889 doi: 10.1097/MD.0000000000001889
|
3 |
Jie Peng, Shaohang Cai, Tao Yu, Yongpeng Chen, Youfu Zhu, Jian Sun. Aspartate aminotransferase to platelet ratio index – a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues. Scandinavian Journal of Clinical and Laboratory Investigation 2016; 76(2): 133 doi: 10.3109/00365513.2015.1125013
|
4 |
W Lu, YP Zhang, HG Zhu, T Zhang, L Zhang, N Gao, DY Chang, J Yin, XY Zhou, MY Li, YT Li, ZZ Li, Q He, Y Geng. Evaluation and comparison of the diagnostic performance of routine blood tests in predicting liver fibrosis in chronic hepatitis B infection. British Journal of Biomedical Science 2019; 76(3): 137 doi: 10.1080/09674845.2019.1615717
|
5 |
Mehmet Koroglu, Muhammed Ali Ayvaz, Suat Baran Bakan, Abdullatif Sirin, Umit Akyuz. Can quantitative surface antigen levels and systemic immune-inflammation index be predictive as a new indicator for the initiation of treatment in chronic hepatitis b?. European Journal of Gastroenterology & Hepatology 2024; 36(4): 489 doi: 10.1097/MEG.0000000000002737
|
6 |
Yu Zhijian, Li Hui, Yao Weiming, Lin Zhanzhou, Chen Zhong, Zheng Jinxin, Wang Hongyan, Deng Xiangbin, Yang Weizhi, Li Duoyun, Liu Xiaojun, Deng Qiwen. Role of the Aspartate Transaminase and Platelet Ratio Index in Assessing Hepatic Fibrosis and Liver Inflammation in Adolescent Patients with HBeAg-Positive Chronic Hepatitis B. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/906026
|
7 |
Ivana Mikolasevic, Lidija Orlic, Sandra Milic, Vesna Lukenda, Sanjin Racki, Davor Stimac, Ervin Avdovic, Luka Zaputovic. Nonalcoholic fatty liver disease (NAFLD) proven by transient elastography in patients with coronary heart disease. Wiener klinische Wochenschrift 2014; 126(15-16): 474 doi: 10.1007/s00508-014-0538-0
|
8 |
Ahmed Ali Al-Qahtani, Hamad Ibrahim Al-Ashgar, Hadeel Al Mana, Mohammed Noreen Al-Ahdal, Ali Soliman Ali, Ahmed Farouk Hasanain, Ahmed Helmy. Impact of Liver Biopsy on the Decision to Treat Patients with Chronic Hepatitis B Genotype D Virus Infection. Intervirology 2014; 57(5): 248 doi: 10.1159/000360858
|
9 |
Fadi ABU BAKER, Randa TAHER NATOUR, Yael KOPELMAN, Abdel H. ALKILANI, Saif ABU MOUCH. Performance of serum-based biomarkers in fibrosis prediction of chronic hepatitis B patients in real life practice. Minerva Gastroenterology 2024; 70(3) doi: 10.23736/S2724-5985.23.03347-8
|
10 |
Bingtian Dong, Guorong Lyu, Yuping Chen, Guofu Lin, Huaming Wang, Ran Qin, Jionghui Gu. Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis B: a meta-analysis. Expert Review of Gastroenterology & Hepatology 2021; 15(9): 1077 doi: 10.1080/17474124.2021.1880894
|
11 |
Agnieszka Bakula, Maciej Dadalski. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 305 doi: 10.1007/978-94-007-7675-3_2
|
12 |
Srinevas K. Reddy, Colleen Reilly, Min Zhan, Ayse L. Mindikoglu, Yixing Jiang, Barton F. Lane, H. Richard Alexander, William J. Culpepper, Samer S. El-Kamary. Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis. Medical Oncology 2014; 31(6) doi: 10.1007/s12032-014-0971-y
|
13 |
Keyur Patel, Sumeet K. Asrani, Maria Isabel Fiel, Deborah Levine, Daniel H. Leung, Andres Duarte-Rojo, Jonathan A. Dranoff, Tarek Nayfeh, Bashar Hasan, Tamar H. Taddei, Yahya Alsawaf, Samer Saadi, Abdul Mounaem Majzoub, Apostolos Manolopoulos, Muayad Alzuabi, Jingyi Ding, Nigar Sofiyeva, Mohammad H. Murad, Mouaz Alsawas, Don C. Rockey, Richard K. Sterling. Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology 2024; doi: 10.1097/HEP.0000000000000842
|
14 |
Marina Manea, Ion Mărunțelu, Ileana Constantinescu. A New Assessment of Two Transferase-Based Liver Enzymes in Low- and High-Fibrosis Patients Chronically Infected with Hepatitis B Virus: A Meta-Analysis and Pilot Study. Journal of Clinical Medicine 2024; 13(13): 3903 doi: 10.3390/jcm13133903
|
15 |
Pinar Korkmaz, Nese Demirturk, Ayse Batırel, Ahmet Cem Yardimci, Unal Cagir, Salih Atakan Nemli, Fatime Korkmaz, Fusun Zeynep Akcam, Huseyin Sener Barut, Burcu Bayrak, Faruk Karakecili, Huseyin Tarakci, Zerrin Yulugkural, Esma Yuksel, Nazlım Aktug Demir, Onur Ural, Sua Sumer, Rezan Harman, Ayten Kadanali, Sinan Ozturk, Sila Cetin Akhan, Necla Eren Tulek, Derya Keten, Alper Sener, Bilgehan Aygen, Aysel Kocagul Celikbas, Fatma Yilmaz Karadag, Gule Aydin, Eyup Arslan, Cahide Sacligil, Gulfem Akengin Ocal, Alpaslan Tanoglu, Asim Ulcay, Ergenekon Karagoz, Nese Saltoglu, Fatma Sırmatel, Hayrettin Akdeniz, Aynur Aynıoglu, Selcan Arslan Ozel, Selmin Dirgen Caylak, Ilhami Celik, Yesim Alpay, Zehra Bestepe Dursun, Muhammed Bekcibasi, Gunay Tuncer Ertem, Arzu Tigli, Elif Sargin Altunok, Kemal Avsar, Kaya Suer, Murat Sayan. Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey. Hepatitis Monthly 2017; (In Press) doi: 10.5812/hepatmon.60266
|
16 |
WeiLin Mao, JianPing Wu. Haematologic indices in hepatitis B virus-related liver disease. Clinica Chimica Acta 2020; 500: 135 doi: 10.1016/j.cca.2019.10.007
|
17 |
Mehmet Coban, Erdim Sertoglu. Should the neutrophil–lymphocyte ratio be used as a noninvasive marker?. European Journal of Gastroenterology & Hepatology 2015; 27(1): 108 doi: 10.1097/MEG.0000000000000235
|
18 |
Bülent Yilmaz, Hayrunnisa Aydin, Güray Can, Zeynep Şentürk, Berna Üstüner, Hasan Yilmaz, Murat Öztürkler, Emir C. Roach, Uğur Korkmaz, Mevlüt Kurt, Altay Çelebi, Ömer Şentürk, Sadettin Hülagü. The relationship between fibrosis level and blood neutrophil to lymphocyte ratio in inactive hepatitis B carriers. European Journal of Gastroenterology & Hepatology 2014; 26(12): 1325 doi: 10.1097/MEG.0000000000000204
|
19 |
Da-Wu Zeng, Jing Dong, Yu-Rui Liu, Jia-Ji Jiang, Yue-Yong Zhu. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection. World Journal of Gastroenterology 2016; 22(29): 6663-6672 doi: 10.3748/wjg.v22.i29.6663
|
20 |
WA. Arsana, BRA. Sidharta, A. Kurniati, JB. Suparyatmo, MID. Pramudianti. Diagnostic Performance of NLR, Type IV Collagen and Fibrosis Score in Chronic Hepatitis B. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 2022; 28(2): 149 doi: 10.24293/ijcpml.v28i2.1826
|
21 |
Ying Peng, Yan Li, Yonghong He, Qinglin Wei, Qiaoling Xie, Liangjun Zhang, Yiju Xia, Xueqian Zhou, Lu Zhang, Xinchan Feng, Kun Chen, Sheng Chen, Wensheng Chen, Qinglin Long, Jin Chai. The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review. Expert Review of Gastroenterology & Hepatology 2018; 12(5): 503 doi: 10.1080/17474124.2018.1463158
|
22 |
Serhat Samanci, Muhammet Kosker. Evaluation of hematological parameters in inactive hepatitis B infection; neutrophil to lymphocyte ratio and mean platelet volume. Medical Journal of the Russian Federation 2022; 28(2): 141 doi: 10.17816/medjrf109318
|
23 |
Lulu Yang, Jiawu Li, Lin Ma, Hongjin Xiang, Du He, Changli Lu, Lin Tang, Yan Luo, Shigao Chen. Noninvasive assessment of liver fibrosis in chronic hepatitis B carriers with sound touch elastography: study of surgical pathology specimens. Expert Review of Medical Devices 2020; 17(8): 845 doi: 10.1080/17434440.2020.1798226
|
24 |
Xue-Ying Xu, Wu-Sheng Wang, Qi-Meng Zhang, Jun-Ling Li, Jin-Bin Sun, Tian-Tian Qin, Hong-Bo Liu. Performance of common imaging techniques <i>vs</i> serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis. World Journal of Clinical Cases 2019; 7(15): 2022-2037 doi: 10.12998/wjcc.v7.i15.2022
|
25 |
Qiang Lu, Changli Lu, Jiawu Li, Wenwu Ling, Xiaoying Qi, Du He, Jianping Liu, Tianfu Wen, Hong Wu, Hongguang Zhu, Yan Luo. Stiffness Value and Serum Biomarkers in Liver Fibrosis Staging: Study in Large Surgical Specimens in Patients with Chronic Hepatitis B. Radiology 2016; 280(1): 290 doi: 10.1148/radiol.2016151229
|
26 |
Agnieszka Bakula, Maciej Dadalski. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_2-1
|